Allopurinol is a prescription medication classified as a xanthine-oxidase inhibitor. It is available in pill form, most commonly in a 300 mg strength. In Hong Kong, the Drug Office of the Department of Health regulates its approval and distribution. Allopurinol is used to lower uric acid levels in the body, which helps prevent gout attacks and complications of hyperuricemia. It is not an analgesic; it works by addressing the biochemical cause of gout-related pain rather than providing direct pain relief.
Allopurinol blocks the enzyme xanthine oxidase, which is responsible for converting purines (substances found in many foods) into uric acid. By inhibiting this enzyme, the drug reduces the production of uric acid, leading to lower serum urate concentrations. The reduction in uric acid helps prevent the formation of monosodium urate crystals that deposit in joints and tissues, the primary trigger of gout flares. Onset of uric acid lowering usually occurs within a few days, with maximal effect reached after several weeks of consistent therapy. Allopurinol is well absorbed from the gastrointestinal tract, and its metabolites are eliminated primarily by the kidneys.
Allopurinol is not indicated for immediate pain relief; it works over time to reduce the frequency and severity of gout attacks.
This article provides educational information about allopurinol and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Allopurinol can be used in mild renal impairment, but the dose usually needs to be reduced (e.g., 100 mg daily) and kidney function should be monitored regularly.
A mild rash is common, but any skin reaction should be reported to a healthcare professional promptly. Severe rashes may require immediate discontinuation of the drug.
Allopurinol is classified as Category B2 in Hong Kong, indicating that it may be used if the potential benefits outweigh the risks. Discuss pregnancy plans with your provider before starting therapy.
Uric acid reduction often begins within a few days, but reaching a stable, target level can take several weeks of consistent dosing.
Alcohol, especially beer, can increase uric acid production and may blunt the effect of allopurinol. Limiting alcohol intake is advisable.
Allopurinol prevents future attacks but does not relieve pain during an acute flare. Non-steroidal anti-inflammatory drugs (NSAIDs) or colchicine are typically used for immediate symptom control.
Both are xanthine-oxidase inhibitors, but febuxostat is a newer, non-purine agent that may be used when allopurinol is not tolerated. Choice depends on individual health status and physician judgment.
Yes. Allopurinol interferes with azathioprine metabolism, so the azathioprine dose should be reduced (often to 25 % of the original dose) under specialist supervision.
Allopurinol is used to prevent uric-acid kidney stones. However, inadequate hydration while on the medication could increase the risk of other stone types, so maintain adequate fluid intake.
Keep the tablets in their original container, protected from heat and moisture. If traveling by air, place the medication in your carry-on bag to avoid temperature extremes in checked luggage.